Register for email alerts and news feeds:
This journal | BMJ Group
rss
Gut 2003;52:917; doi:10.1136/gut.52.7.917-a
Copyright © 2003 BMJ Publishing Group Ltd & British Society of Gastroenterology.
Gut 2003;52:917
© 2003 by BMJ Publishing Group & British Society of Gastroenterology

Digest

Robin Spiller, Editor

The first 150 words of the full text of this article appear below.

SAFETY OF LONG TERM OMEPRAZOLE

Omeprazole is one of the most widely prescribed medications, being used both for the symptomatic treatment of gastro-oesophageal reflux and also to prevent NSAID associated peptic ulcer. The results of the recent survey of mortality in 18 000 people treated with omeprazole is therefore of great interest. While there is a modest increase in mortality from circulatory, respiratory, and musculoskeletal disorders in the first year after initiating treatment, this fell to the expected level by year 4, strongly suggesting that the observed increased mortality was due more to the underlying disease for which omeprazole was prescribed, than the drug itself. A different pattern was observed in neoplasmas of the oesophagus and cirrhosis, conditions which both showed a continuing excess over a period of four years from commencing treatment. When examined more closely, the risk for oesophageal cancer was only increased in those with Barrett’s oesophagus, a condition known to be . . . [Full text of this article]


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Hepatic 31P MRS in rat models of chronic liver disease: assessing the extent and progression of disease
I R Corbin, R Buist, J Peeling, M Zhang, J Uhanova, and G Y Minuk
Gut 2003 52: 1046-1053. [Abstract] [Full Text] [PDF]

Increased tumour necrosis factor {alpha} production in mesenteric lymph nodes of cirrhotic patients with ascites
J Genescà, R Martí, F Rojo, F Campos, V Peribáñez, A Gónzalez, L Castells, C Ruiz-Marcellán, C Margarit, R Esteban, J Guardia, and R Segura
Gut 2003 52: 1054-1059. [Abstract] [Full Text] [PDF]

Mortality study of 18 000 patients treated with omeprazole
D N Bateman, D Colin-Jones, S Hartz, M Langman, R F Logan, J Mant, M Murphy, K R Paterson, R Rowsell, S Thomas, and M Vessey
Gut 2003 52: 942-946. [Abstract] [Full Text] [PDF]

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs